Times Square Capital Management, LLC Bluebird Bio, Inc. Transaction History

Times Square Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 12, 2021	SELL	$16.59 - $33.89 $3.15 Million - $6.44 Million	-189,900 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$27.5 - $37.92 $17 Million - $23.4 Million	-617,900 Reduced 76.49%	189,900 $8.22 Million
Q3 2020 Nov 06, 2020	SELL	$34.44 - $43.75 $4.47 Million - $5.68 Million	-129,795 Reduced 13.84%	807,800 $43.6 Million
Q2 2020 Aug 07, 2020	BUY	$27.12 - $45.97 $4.1 Million - $6.96 Million	151,330 Added 19.25%	937,595 $57.2 Million
Q1 2020 May 08, 2020	BUY	$26.16 - $63.5 $6.16 Million - $14.9 Million	235,290 Added 42.7%	786,265 $36.1 Million
Q4 2019 Feb 05, 2020	BUY	$46.96 - $61.67 $25.9 Million - $34 Million	550,975 New	550,975 $48.3 Million

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $27M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Times Square Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Times Square Capital Management, LLC with notifications on news.